Log in to save to my catalogue

The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary P...

The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary P...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2344192129

The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention

About this item

Full title

The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention

Publisher

Los Angeles, CA: SAGE Publications

Journal title

Clinical and applied thrombosis/hemostasis, 2015-11, Vol.21 (8), p.783-789

Language

English

Formats

Publication information

Publisher

Los Angeles, CA: SAGE Publications

More information

Scope and Contents

Contents

Aim:
We aimed to investigate the 6-month efficacy and safety of postprocedural 12-hour tirofiban administration versus 24-hour tirofiban administration in patients with ST-segment elevated myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI).
Methods:
This retrospective study enrolled 349 patients wi...

Alternative Titles

Full title

The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2344192129

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2344192129

Other Identifiers

ISSN

1076-0296

E-ISSN

1938-2723

DOI

10.1177/1076029614529841

How to access this item